RxDoctor Payments Data

Madison Newell, PA

Physician Assistant · Grandview, MONPI 1306537634

Payments from drug & device makers

$2,216in general payments, 2019–2025

Across 122 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$321
  • Novo Nordisk$283
  • Abbott$235
  • Pfizer$221
  • AbbVie$181
  • Amgen$171
  • plus $803 from 18 others

What the payments were for

  • Food & beverage$2,216100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,216 in reported general payments places this provider in the 85th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$41,876
Medicare patients
205
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$37,923
JardianceEmpagliflozin13$18,249
ArexvyRsvpref3 Antigen/As01e/Pf23$6,196
Atorvastatin Calcium101$1,759
Omeprazole51$1,676
Albuterol Sulfate HfaAlbuterol Sulfate70$1,329
SynthroidLevothyroxine Sodium11$1,112
Tamsulosin Hcl19$815
Rosuvastatin Calcium89$737
Gabapentin42$688
Fluticasone Propionate16$671
ValacyclovirValacyclovir Hcl12$668
Montelukast Sodium40$623
Levothyroxine Sodium75$589
Lisinopril81$547

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$283$37,92335 claims
Boehringer IngelheimJardiance$29$18,24913 claims
GSKArexvy$28$6,19623 claims
AbbVieSynthroid$181$1,11211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Grandview

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →